Benzinga's M&A Chatter for Friday February 22, 2013

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday February 22, 2013: Ark Restaurants Rejects Landry's $22/Share Bid The Rejection:
Ark Restaurants ARKR said Friday that its Board of Directors has decided that the unsolicited proposal from Landry's to acquire Ark Restaurants for $22 per share is inadequate and not in the best interests of Ark Restaurants shareholders. Michael Weinstein, Chairman and CEO of Ark Restaurants, commented: “The Board believes that the proposal by Landry's significantly undervalues the Company and its future prospects. In the Board's judgment, Ark's shareholders will be better served by our experienced management operating and growing our business.” Ark Restaurants closed at $21.42 Friday, a gain of 1.5% on 3 times average volume. Report Gardner Denver Board to Meet Monday to Consider KKR's $75/Share Offer The Rumor:
The Board of Direcrtors of Gardner Denver GDI will meet on Monday to consider KKR's KKR $75 per share bid, according to Reuters. On Thursday, Bloomberg had reported the $3.7 billion offer for KKR. KKR has declined comment, while Gardner Denver has not responded. Gardner Denver closed at $70.84 Friday, a gain of 5% on 3.5 times average volume. BGI-Shenzhen Extends Tender Offer Again for Complete Genomics The Tender Offer:
BGI-Shenzhen said Friday that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics GNOM, for $3.15 per share, to 12:00 midnight (New York City time) on Friday, March 1, 2013. The Offer was previously scheduled to expire at 12:00 midnight (New York City time) on Friday, February 22, 2013. Complete Genomics closed at $3.11 Friday, a loss of $0.01 on lower than average volume.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!